Clinical trial registry record

Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated November 22, 2021.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT04558450
Last registry update
November 22, 2021
Status
Recruiting
Phase
Phase not reported
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
360
Countries
France
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NON RANDOMIZED · SINGLE GROUP · DIAGNOSTIC · NONE
Evidence population
Human clinical study registration
Participants
360
Population
ALL · 18 Years
Duration
2020-09-21 to 2033-03-01
Intervention
carotid-femoral pulse-wave velocity
Comparator
Not reported
Outcomes measured
PWV — 6 months after COVID19 infection; PWV — 12 months after COVID19 infection; PWV change — difference between PWV at 12 and 6 months after COVID19 infection; arterial distensibility — 6 months after COVID19 infection; arterial distensibility — 12 months after COVID19 infection; arterial distensibility change — difference between arterial distensibility at 12 and 6 months after COVID19 infection; brachial artery FMD — 6 months after COVID19 infection; brachial artery FMD — 12 months after COVID19 infection; brachial artery FMD change — difference between FMD at 12 and 6 months after COVID19 infection; central blood pressure — 6 months after COVID19 infection; central blood pressure — 12 months after COVID19 infection; central blood pressure (BP) change — difference between central BP at 12 and 6 months after COVID19 infection; wave separation/wave intensity analysis (WSA/WIA) — 6 months after COVID19 infection; wave separation/wave intensity analysis (WSA/WIA) — 12 months after COVID19 infection; WSA/WIA change — difference between WSA/WIA at 12 and 6 months after COVID19 infection; cardiac diastolic dysfunction — 6 months after COVID19 infection; cardiac diastolic dysfunction — 12 months after COVID19 infection; cardiac diastolic dysfunction change — difference between cardiac diastolic dysfunction at 12 and 6 months after COVID1…; myocardial stiffness — 6 months after COVID19 infection; myocardial stiffness — 12 months after COVID19 infection
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cardiovascular ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

cardiovascular aging
Read the original source →Export JSON